Companies: 10,795·Total market cap: $144.5T
Invion Limited

Invion Limited

IVIXFOTCHealthcare● Active
$0.00
$-0.04(-95.12%)
Market Cap$174538
P/E Ratio
52W High$0.0369
52W Low$0.0018

Invion Limited (IVIXF) Revenue

Annual & quarterly revenue history · segment & region breakdown

IVIXF · revenue · updated Jun 9, 2026

Core revenue metrics

Invion Limited trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2025.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
-100.00%
vs FY2025 $0.00B
Price / sales
0.37×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$119K
4 employees
FY2025
$0.00B
FY2024
$0.00B
5Y CAGR
+-100.0%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Invion Limited SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

20252016 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-06-30$0.00B-$0.00B-100.00%
2024-06-30$0.00B-$0.00B-9.92%
2023-06-30$0.00B+$0.00B+20.36%
2022-06-30$0.00B+$0.00B+29.85%
2021-06-30$0.00B-$0.00B-26.92%
2020-06-30$0.00B-$0.00B-12.13%
2019-06-30$0.00B+$0.00B+399.81%
2018-06-30$0.00B+$0.00B
2017-06-30$0.00B+$0.00B
2016-06-30$0.00B
IVIXF revenue by year · IVIXF revenue history · IVIXF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Invion Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Invion Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Invion Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

IVIXF revenue · 4 questions

IVIXF's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2025.

IVIXF revenueIVIXF annual revenuewhat is IVIXF revenueIVIXF TTM revenue

Source: FMP · Invion Limited SEC filings · GAAP · Invion Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026